Colorectal Cancer Outcomes and Treatment Patterns in Patients Too Young for Average-Risk Screening

Por Abdelsattar, Zaid, Wong, Sandra, Regenbogen, Scott, Jomaa, Diana, Hardiman, Karin, Hendren, Samantha
Publicado no Cancer (2016)

Rapamycin Inhibition of Polyposis and Progression to Dysplasia in a Mouse Model

Por Hardiman, Karin M., Liu, Jianhua, Feng, Ying, Greenson, Joel K., Fearon, Eric R.
Publicado em 2014

HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling

Por Xue, Xiang, Jungles, Kylie, Onder, Gunseli, Samhoun, Jalal, Győrffy, Balázs, Hardiman, Karin M.
Publicado no Oncotarget (2016)

A Patient-Autonomy-Centered Self-Care Checklist Reduces Hospital Readmissions After Ileostomy Creation

Por Hardiman, Karin M., Reames, Christina D., McLeod, Marshall C., Regenbogen, Scott E.
Publicado no Surgery (2016)

Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6

Por Ziemke, Elizabeth K., Dosch, Joseph S., Maust, Joel D., Shettigar, Amrith, Sen, Ananda, Welling, Theodore H., Hardiman, Karin M., Sebolt-Leopold, Judith S.
Publicado no Clin Cancer Res (2015)

HPC2 1-B3: A Novel Monoclonal Antibody to Screen for Pancreatic Ductal Dysplasia

Por Morgan, Terry K., Hardiman, Karin, Corless, Christopher L., White, Sandra L., Bonnah, Robert, Van de Vrugt, Henry, Sheppard, Brett C., Grompe, Markus, Cosar, Ediz F., Streeter, Philip R.
Publicado em 2012

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

Por Dosch, Joseph, Ziemke, Elizabeth, Wan, Shanshan, Luker, Kathryn, Welling, Theodore, Hardiman, Karin, Fearon, Eric, Thomas, Suneetha, Flynn, Matthew, Rios-Doria, Jonathan, Hollingsworth, Robert, Herbst, Ronald, Hurt, Elaine, Sebolt-Leopold, Judith
Publicado no Oncotarget (2017)

Intra-tumor Genetic Heterogeneity in Rectal Cancer

Por Hardiman, Karin M., Ulintz, Peter J., Kuick, Rork, Hovelson, Daniel H., Gates, Christopher M., Bhasi, Ashwini, Grant, Ana Rodrigues, Liu, Jianhua, Cani, Andi K., Greenson, Joel, Tomlins, Scott, Fearon, Eric R.
Publicado no Lab Invest (2015)

Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer

Por Xue, Xiang, Bredell, Bryce X., Anderson, Erik R., Martin, Angelical, Mays, Christopher, Nagao-Kitamoto, Hiroko, Huang, Sha, Győrffy, Balázs, Greenson, Joel K., Hardiman, Karin, Spence, Jason R., Kamada, Nobuhiko, Shah, Yatrik M.
Publicado no Proc Natl Acad Sci U S A (2017)

Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis

Por Xue, Xiang, Ramakrishnan, Sadeesh K., Weisz, Kevin, Triner, Daniel, Xie, Liwei, Attili, Durga, Pant, Asha, Győrffy, Balázs, Zhan, Mingkun, Carter-Su, Christin, Hardiman, Karin M., Wang, Thomas D., Dame, Michael K., Varani, James, Brenner, Dean, Fearon, Eric R., Shah, Yatrik M.
Publicado no Cell Metab (2016)

BRAF(V600E) cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis

Por Sakamoto, Naoya, Feng, Ying, Stolfi, Carmine, Kurosu, Yuki, Green, Maranne, Lin, Jeffry, Green, Megan E, Sentani, Kazuhiro, Yasui, Wataru, McMahon, Martin, Hardiman, Karin M, Spence, Jason R, Horita, Nobukatsu, Greenson, Joel K, Kuick, Rork, Cho, Kathleen R, Fearon, Eric R
Publicado no eLife (2017)